Can AI fix what's broken inside pharma — or is it too high-stakes and too guarded to let AI in? Jonathan Green talks with pharmaceutical expert Wendy Rockwell about the realities of bringing AI into one of the most regulated, security-conscious industries on earth: million-dollar legacy systems, painfully long buying cycles, and the trust problem when AI gives you two different answers to the same question.
Key Takeaways:
• Pharma is high-stakes — a wrong answer isn't an inconvenience, it's a risk
• Legacy systems cost millions and fragment across regions, making AI adoption hard
• AI's inconsistency (same question, different answers) is a real blocker in regulated work
• The industry is extremely guarded — security and internet restrictions slow everything
• Long buying cycles mean AI has to prove itself before it gets in the door
Notable Quotes:
"You can ask the same question twice and get two different answers." — Wendy Rockwell
"We're really, really, really guarded." — Wendy Rockwell
Connect with Wendy Rockwell:
LinkedIn: https://www.linkedin.com/in/wendy-rockwellmba
Enjoyed this? Follow The Artificial Intelligence Podcast and share it with someone in healthcare or pharma.
Connect with Jonathan Green